PMV Pharmaceuticals (PMVP) Long-Term Investments (2021 - 2025)

PMV Pharmaceuticals (PMVP) has 5 years of Long-Term Investments data on file, last reported at $6.0 million in Q2 2025.

• Quarterly Long-Term Investments changed N/A year-over-year to $6.0 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $6.0 million (changed N/A YoY) and the FY2024 annual result came in at $13.8 million, down 45.72% from the prior year.
• Long-Term Investments climbed to $6.0 million in Q2 2025, from $5.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $36.2 million in Q3 2023 to a low of $2.5 million in Q4 2022.
• A 5-year average of $16.9 million and a median of $16.0 million in 2021 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments plunged 85.25% — and 2023, when it soared 922.24%.
• Tracing PMVP's Long-Term Investments over 5 years: stood at $16.9 million in 2021, then sank by 85.25% to $2.5 million in 2022, then soared by 922.24% to $25.5 million in 2023, then sank by 45.72% to $13.8 million in 2024, then sank by 56.43% to $6.0 million in 2025.
• The last three Long-Term Investments figures came in at $6.0 million (Q2 2025), $5.4 million (Q1 2025), and $13.8 million (Q4 2024), per Business Quant data.